ProCE Banner Activity

Bipolar Depression: Current and Future Options

Clinical Thought

Many agents exist for treatment of unipolar depression, but they don&rsquo t always translate into effective treatments for bipolar depression. In this commentary, an expert sheds light on the unmet treatment needs in bipolar depression and some of the promising research aiming to identify more effective treatment options.

Released: December 23, 2022

Expiration: December 22, 2023

Share

Faculty

Michael Asbach

Michael Asbach, DMSc, PA-C, Psych-CAQ

Associate Director
Interventional Psychiatry
DENT Neurologic Institute
Amherst, New York

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

AbbVie Inc.

Intra Cellular Therapies

Faculty Disclosure

Primary Author

Michael Asbach, DMSc, PA-C, Psych-CAQ

Associate Director
Interventional Psychiatry
DENT Neurologic Institute
Amherst, New York

Michael Asbach, DMSc, PA-C, Psych-CAQ: consultant/advisor/speaker: AbbVie, Avanir, Biogen, Intracellular, Janssen, Neurocrine, Otsuka.